STEPHANIE BARNES: Open Payments
NPI 1477738342 · LITTLE ROCK, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$271 in 11 payments from 8 companies in 2025. Trend: 2023 $89 · 2024 $214 · 2025 $271
Food & beverage: $271
| Company | Payments | Amount |
|---|---|---|
| Boston Scientific Corporation | 1 | $58 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $54 |
| E.R. Squibb & Sons, L.L.C. | 2 | $38 |
| Janssen Pharmaceuticals, Inc | 1 | $32 |
| Teva Pharmaceuticals USA, Inc. | 2 | $32 |
| ABBVIE INC. | 1 | $20 |
| Otsuka America Pharmaceutical, Inc. | 1 | $20 |
| Lilly USA, LLC | 1 | $18 |
Products named: CDS - MCT/CEM Monitoring, CAPLYTA, COBENFY, INVEGA SUSTENNA, UZEDY, VRAYLAR, ABILIFY MAINTENA, MOUNJARO.
Industry payments across AR — which companies pay providers there.
